Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides

By sjmartinez • July 1, 2025

Murugesan P, Zhang Y, Zhang Y, Youn JY, Cai H. Novel and superior treatment of pulmonary hypertension with netrin-1 derived, modified and improved small peptides. Redox Biol. 2025 Jun 13;85:103710. doi: 10.1016/j.redox.2025.103710. Epub ahead of print. PMID: 40580754.

Tags: Cardiology/Epi, Endothelial nitric oxide synthase uncoupling, eNOS, hypoxia, Mitochondrial superoxide production, Netrin-1, Netrin-1 derived small peptides, NO bioavailability, Publications, pulmonary hypertension, Pulmonary vascular remodeling, reactive oxygen species, Right ventricular hypertrophy, ROS, Translational

Related Posts

Heart Failure Quality of Care Among Asian Patients in the United States

Huang X, Huffman MD, Kandula NR, Petito LC, Agarwal A, Yancy CW, Fonarow GC, Jhund PS, Mefford MT, Reynolds KL, Khan SS, Shah NS. Heart[...]

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]